OBJECTIVE: To examine the role of sociodemographic factors (age, race/ethnicity, and sex) and socioeconomic factors (income and education) in the utilization of rheumatology subspecialty care in a large cohort of subjects with systemic lupus erythematosus (SLE). METHODS: Data were derived from a cohort of 982 English-speaking subjects with SLE. Between 2002 and 2004, trained survey workers administered a telephone survey to subjects eliciting information regarding demographics, SLE disease status, medications, health care utilization, health insurance, and socioeconomic status. We identified predictors of utilization of rheumatology subspecialty care, defined as at least 1 visit to a rheumatologist in the previous year. In addition, we examined factors associated with identifying any specialist as primarily responsible for SLE care. RESULTS: Older age, lower income, Medicare insurance, male sex, and less severe disease were associated with lack of rheumatology care. However, race/ethnicity and educational attainment were not significantly related to seeing a rheumatologist. After multivariate adjustment, only older age, lower income, and male sex remained associated with absence of rheumatology visits. Those least likely to identify a specialist as primarily responsible for their SLE care included older subjects and those reporting lower incomes. CONCLUSION: Although elderly subjects and those with lower incomes traditionally have access to health care through the Medicare and Medicaid programs, the presence of health insurance alone did not ensure equal utilization of care. This finding suggests that additional barriers to accessing rheumatology subspecialty care may exist in these patient populations.
OBJECTIVE: To examine the role of sociodemographic factors (age, race/ethnicity, and sex) and socioeconomic factors (income and education) in the utilization of rheumatology subspecialty care in a large cohort of subjects with systemic lupus erythematosus (SLE). METHODS: Data were derived from a cohort of 982 English-speaking subjects with SLE. Between 2002 and 2004, trained survey workers administered a telephone survey to subjects eliciting information regarding demographics, SLE disease status, medications, health care utilization, health insurance, and socioeconomic status. We identified predictors of utilization of rheumatology subspecialty care, defined as at least 1 visit to a rheumatologist in the previous year. In addition, we examined factors associated with identifying any specialist as primarily responsible for SLE care. RESULTS: Older age, lower income, Medicare insurance, male sex, and less severe disease were associated with lack of rheumatology care. However, race/ethnicity and educational attainment were not significantly related to seeing a rheumatologist. After multivariate adjustment, only older age, lower income, and male sex remained associated with absence of rheumatology visits. Those least likely to identify a specialist as primarily responsible for their SLE care included older subjects and those reporting lower incomes. CONCLUSION: Although elderly subjects and those with lower incomes traditionally have access to health care through the Medicare and Medicaid programs, the presence of health insurance alone did not ensure equal utilization of care. This finding suggests that additional barriers to accessing rheumatology subspecialty care may exist in these patient populations.
Authors: J Sánchez-Guerrero; A Villegas; A Mendoza-Fuentes; J Romero-Díaz; G Moreno-Coutiño; M C Cravioto Journal: Am J Med Date: 2001-10-15 Impact factor: 4.965
Authors: Steven M Asch; Eve A Kerr; Joan Keesey; John L Adams; Claude M Setodji; Shaista Malik; Elizabeth A McGlynn Journal: N Engl J Med Date: 2006-03-16 Impact factor: 91.245
Authors: J Calvo-Alén; J D Reveille; V Rodríguez-Valverde; G McGwin; B A Baethge; A W Friedman; G S Alarcón Journal: Lupus Date: 2003 Impact factor: 2.911
Authors: Chris Tonner; Laura Trupin; Jinoos Yazdany; Lindsey Criswell; Patricia Katz; Edward Yelin Journal: Arthritis Care Res (Hoboken) Date: 2010-06 Impact factor: 4.794
Authors: Edith M Williams; J Madison Hyer; Ramakrishnan Viswanathan; Trevor D Faith; Leonard Egede; Jim C Oates; Gailen D Marshall Journal: Hum Immunol Date: 2017-07-14 Impact factor: 2.850
Authors: C H Feldman; B L Bermas; M Zibit; P Fraser; D J Todd; P R Fortin; E Massarotti; K H Costenbader Journal: Lupus Date: 2012-10-19 Impact factor: 2.911
Authors: Jennifer Waljee; Lin Zhong; Onur Baser; Huseyin Yuce; David A Fox; Kevin C Chung Journal: J Bone Joint Surg Am Date: 2015-03-04 Impact factor: 5.284
Authors: Candace H Feldman; LeRoi S Hicks; Tabatha L Norton; Elmer Freeman; Daniel H Solomon Journal: J Clin Rheumatol Date: 2013-10 Impact factor: 3.517
Authors: Candace H Feldman; Linda T Hiraki; Jun Liu; Michael A Fischer; Daniel H Solomon; Graciela S Alarcón; Wolfgang C Winkelmayer; Karen H Costenbader Journal: Arthritis Rheum Date: 2013-03